• Boule Diagnostics will hold an extraordinary general meeting at its premises in Spånga on December 7, 2026.
• Shareholders will vote on a three-for-one rights issue of up to 116,499,312 shares at SEK 0.80 each.
• A proposed directed issue covers up to 78,352,790 shares at SEK 0.80 each for external investors not fully allocated rights-issue shares.
• Proposed loan amendments would enable debt-to-equity offsets and extend remaining loan maturities to June 30, 2028.
• Other proposals include revised share-count limits and a share-capital reduction of up to SEK 48.71 million without canceling shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Boule Diagnostics AB published the original content used to generate this news brief on November 04, 2026, and is solely responsible for the information contained therein.